Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

AstraZeneca has agreed to sell its Alderley Park site in Cheshire, United Kingdom (UK) to Manchester Science Parks, a Greater Manchester-based public-private partnership and science park operator. The sale is part of AstraZeneca's...

Almac is expanding its clinical services and technologies capabilities to include on-the-ground leadership as well as technical, project and operational resources in Asia. Almac is strengthening its Asia Pacific offerings by establishing a new...

Ranbaxy Inc. has initiated a nationwide voluntary Class II recall of atorvastatin calcium tablets, 10 mg, 90-count tablets per bottle, prescription only, based on a product complaint was received by a pharmacist who discovered an...

Caraco Pharmaceutical Laboratories, Ltd. issued a Class II recall of the diabetes drug metformin HCl extended-release  (ER) tablets, USP, 500 mg, prescription only, 500-count bottles due to the presence of foreign tablet based on a...

Takeda Pharmaceutical Company Limited has submitted a new drug application  to the Japanese Ministry of Health, Labor and Welfare for trelagliptin succinate, a treatment for Type 2 diabetes. Trelagliptin succinate, discovered by Takeda...

Teva Pharmaceutical Industries Ltd. has launched the generic equivalent to Xeloda® (capecitabine) tablets, 150 mg and 500 mg, in the United States. Xeloda® is marketed by Genentech in the United States. Teva was the first to receive approval on...

GlaxoSmithKline plc announced  that following the voluntary open offer undertaken by its subsidiary, GlaxoSmithKline Pte Ltd, GSK has successfully increased its stake in its publicly listed pharmaceuticals subsidiary in India (GlaxoSmithKline...

Pfizer Inc. is voluntarily recalling one lot of 30-count Effexor XR® (venlafaxine HCl) 150 mg extended-release capsules, one lot of 90-count Effexor XR (venlafaxine HCl) 150 mg extended-release capsules, and one lot of 90-count Greenstone...

Baxter International Inc. has initiated a voluntary recall in the US of a single lot of DIANEAL PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose 6000mL (Ambu-Flex II) to the hospital/user level. The recall is being initiated as a...

Daiichi Sankyo Company Limited announced a series of organizational and personnel changes, effective April 1, 2014. Organizationally, within its Corporate Strategy Division, the current Corporate Strategy Department and the Global Brand...

Eisai Co., Ltd. and Biogen Idec have entered into a collaboration to develop and commercialize two of Eisai's clinical candidates for Alzheimer's disease (AD), E2609 and BAN2401. The agreement also provides Eisai with an option to jointly...